View on market: Stay Cautious, be with quality business:

Stocks in Asia caught a modest tailwind Friday from a US rally sparked by hopes that policy makers can get inflation under control without causing a global economic downturn. Shares advanced in Japan, South Korea and Australia. US equity futures edged down after the best Wall Street session in two weeks swept along everything from speculative investments to technology titans. At 7:05 am, the Singapore-traded SGX Nifty — an early barometer of India’s benchmark Nifty 50 — rose 0.84% to 16,268.5. Elsewhere, West Texas Intermediate crude was below $103/barrel, putting the US benchmark on course for a weekly fall about 5%. Prices have swung in a range of more than $16 this week, which saw both WTI and global benchmark Brent briefly drop below $100.

Economic Calendar:

  • INR: Forex Reserve on 8th July 2022.
  • INR: IIP Data 12th July 2022.
  • USD: ADP Nonfarm Employment 08th July, 2022.
  • USD: Trade Balance 08th July, 2022.

Q1FY23 Result Today: TCS

Vakrangee Q1 FY23 (Consolidated, QoQ) Revenue up 8% at Rs 226.02 crore EBIT down 87% at Rs 4.63 crore EBIT margin at 2.05% vs 17.53% Net profit down 85% at Rs 4.52 crore

Brokerage Radar:

JEFFERIES ON SHREE CEMENT: Upgrade to hold, TP Rs 20000 AR highlights 1)+ve demand outlook 2) strong focus on green energy, alternate fuels, logistic savings 3) eyes respite from cost inflation from 2HFY23 4) reiterates 80MTPA capacity by 2030.

CLSA ON TVS: Buy, TP raised to Rs 922 (on roll fwd) Ronin launch marks entry into cruiser motorcycle segment Raise volume & earnings estimates on back of this launch Co gaining market share on back of strong launches.

MOTILAL OSWAL ON ICICI LOMBARD: Initiate Buy, TP Rs 1500 Successfully weathering storm Investing in growth amid favorable industry dynamics During FY22-24, see co delivering a premium/PAT CAGR of 19%/28% & a RoE of 19.1% in FY24 Trading closer to its trough P/E multiple.

GOLDMAN SACHS ON BANKS: India financials underperformed regional financials by 6% YTD & now trading @ 10-yr avg val gap despite earnings upgrades Expect earnings momentum to continue Current underperformance provides an opportunity to add Buys- SBI, ICICI & Kotak Sells- Bajaj Fin & SBI Cards

International Markets:

U.S & Europe:

Particulars      07th June    Chg Chg(%)
Nasdaq 11,621.35 259.5 2.28
Dow 31384.55 346.87 1.12
FTSE 7,189.08 81.31 1.14
CAC 6,006.70 94.32 1.6
DAX 12,843.22 248.7 1.97
Dow Fut.* 31367.2 -57.3 -0.17

Asian markets:

Particulars    08th July    Chg. Chg(%)
SGX Nifty 16,265.50 132.5 0.82
Nikkei 26,858.67 368.14 1.39
Straits Times 3,126.19 -3.21 -0.1
Hang Seng 21,773.28 129.7 0.6
Shanghai 3,364.37 -0.03 0

ADR Watch:

Particulars     07th June Chg. Chg.(%)
Dr Reddy 55.84 0.57 1.03
HDFC Bank 59.47 2.34 4.1
ICICI Bank 19.05 0.57 3.08
Infosys 19.16 0.23 1.22
Tata Motor 27.7 1.28 4.84
Wipro 5.46 0.1 1.87

Commodities & Currency

Particulars Current Price Chg(%)
USD/INR 79.18  -0.16
Brent 104.38 -0.20
Gold 1740.80  0.06
Silver 19.125  -0.31


Particulars         07th June         06th June 
FIIs -925.22                     -330.13                    
DIIs  980.59  1464.33

News Update:

Mahindra & Mahindra: The company has agreed to sell stake in its new electric vehicle arm to British International Investment Plc.

Coforge: The company is in alliance with Newgen Software to help organisations transform current processes, enhance operational efficiency, and gain a competitive edge over peers.

Vedanta: The company will acquire Athena Chhattisgarh Power, a 1,200 MW coal-based power plant, for Rs 564.67 crore.

PowerGrid: CBI has arrested the company’s executive director BS Jha and five others in connection with a bribery case. Rs 93 lakh was recovered from Jha’s residence in Gurugram.

Dr Reddy’s: The US Food and Drug Administration has issued a Form 483 with two observations to Dr Reddy’s formulations manufacturing facility in Andhra Pradesh.

Tata Motors: JLR sales fell 37% year-on-year to 78,825 units in quarter ended June 30 due to a global chip shortage, covid lockdowns in China, and new model transition of Range Rover Sport.

Star Health: The Company’s gross direct premium rose 13% year-on-year to Rs 2,466.2 crore in the June quarter.

Adani Ports and SEZ: The Company has appointed D. Muthukumaran as the chief financial officer with effect from July 25.

Alkem Laboratories: The Company has received Form 483 with one observation from the U.S. FDA with respect to ANDA filed for products to be manufactured at its plant in Indore.

Eveready: The board has passed the resolution to formally designate Dabur’s Burman family as promoters of the company after the completion of open offer.

Source: Moneycontrol, Livemint,, Bloomberg, Investing

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited,
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting, or emailing with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website:
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL